A
ATAI Life Sciences
A biotechnology company pioneering mental health innovation
At a glance
- Status
- Listed
- Listing
- IPO 2021
Open roles
ATAI Life Sciences in the Berlin ecosystem
The ATAI Life Sciences office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed2 investors entered at this stage
- AGApeiron Investment Group
- HCHCS
Series A3 investors entered at this stage
- TBThor Bjorgolfsson
- MNMike Novogratz
Peter Thiel
Series B and later16 investors entered at this stage
- WVWhat If Ventures
- FVFearless Ventures
- WPWoodline Partners
- MSMaryanna Saenko
- EKEfrem Kamen
- HMHighline Capital Management
- CMCatalio Capital Management
Alpha Wave Global- PIPura Vida Investments
- TCThiel Capital
- SJSteve Jurvetson
- FVFuture Ventures
- NVNeo Kuma Ventures
- CAChristian Angermayer
- SCSubversive Capital
- GDGalaxy Investment Partners (Galaxy Digital)
Source: Dealroom Talent Intelligence.
Alumni founders
Former ATAI Life Sciences employees who went on to found companies, sorted by Dealroom signal score.
CLCentenara LabsEst. 2019
Christian AngermayerSwitzerland
THThirdwebEst. 2021
Steven BartlettUnited States
KHKanna HealthEst. 2021
Lars Christian WildeUnited KingdomGlobal footprint
Patents
77 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Investments and acquisitions
Disclosed deals where ATAI Life Sciences was the backer or acquirer, 2020–2025. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
9 deals across ATAI Life Sciences's capital deployment.
Where the deals concentrate by sector, stage, and decade.
Where ATAI Life Sciences deploys vs peers
Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.
ATAI Life Sciences's portfolio, mapped.
See ATAI Life Sciences on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.
Lilly acquires ATAI / AtaiBeckley (September 2026)